DARE

Dare Bioscience Inc

• Seeking Alpha·03/26 22:56

  Daré outlines 2026 revenue launch and multiplatform strategy as DARE to PLAY expands nationwide

• NASDAQ·03/26 21:20

  Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Lags Revenue Estimates

• Seeking Alpha·03/26 20:07

  Dare Bioscience GAAP EPS of -$1.20 beats by $0.45, revenue of $1.03M beats by $0.26M

• Benzinga·03/26 20:05

  Dare Bioscience Q4 EPS $(0.02) Beats $(0.43) Estimate, Sales $1.024M Beat $375.750K Estimate

• Reuters·03/26 20:03

  Dare Bioscience FY2025 net loss widens 231% to $(13.0) million; revenue climbs 10,429% to $1.0 million

• Reuters·03/26 20:01

  DARÉ BIOSCIENCE REPORTS FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

• Seeking Alpha·03/26 14:00

  Here are the major earnings after the close Thursday

• Benzinga·03/26 11:11

  Earnings Scheduled For March 26, 2026

• Seeking Alpha·03/25 21:35

  Dare Bioscience FY 2025 Earnings Preview

• Reuters·03/20 12:02

  Daré Bioscience to host full-year 2025 financial results conference call and webcast

• Benzinga·03/17 21:12

  12 Health Care Stocks Moving In Tuesday's After-Market Session

• TipRanks·03/17 21:00

  Daré Bioscience Completes Regulation A Preferred Stock Offering

• TipRanks·03/16 12:39

  Dare Bioscience receives NIH funding award notice for DARE-PTB1

• Benzinga·03/16 12:08

  Daré Bioscience Gets ~$2M Funding From National Institutes Of Health's Division For Its Intravaginal Ring DARE-PTB1 For Prevention Of Preterm Birth